Imaging and Staging of Endometrial cancer

Publication date: Available online 18 April 2019Source: Seminars in Ultrasound, CT and MRIAuthor(s): S.C. Faria, C.E. Devine, B. Rao, T. Sagebiel, P. BhosaleAbstractEndometrial carcinoma is the most common female pelvic malignancy in the United States. Although endometrial cancer is staged according to the International Federation of Gynecology and Obstetrics (FIGO) surgical system, early and accurate diagnostic assessment of disease status of gynecologic malignancies is important for optimal treatment planning and outcome prediction. Preoperative imaging may assist in evaluation of local extent and detection of distant metastatic disease guiding the optimal course of treatment. Several imaging techniques such as transvaginal ultrasound (TVS), computed tomography (CT), and magnetic resonance imaging (MRI) have been used as tools for pre-operative staging of endometrial cancer. PET/CT and more recently, PET/MRI have also been used in the management of endometrial cancer.Cross-sectional imaging, especially MRI, may detect gross myometrial invasion or extension of tumor to the cervical stroma which can alter management. Imaging studies can also evaluate the presence of lymph nodal involvement, and detect local and distant metastatic disease at diagnosis. Additionally, imaging also plays a role in the monitoring of treatment and surveillance of the patients for detection of early recurrent disease.In this article, we will review the imaging and staging of endometrial cancer.
Source: Seminars in Ultrasound, CT and MRI - Category: Radiology Source Type: research